Compare Abbott India with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SHASUN PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SHASUN PHARMA ABBOTT INDIA/
SHASUN PHARMA
 
P/E (TTM) x 43.2 123.9 34.8% View Chart
P/BV x 12.4 8.5 144.8% View Chart
Dividend Yield % 0.6 0.2 239.6%  

Financials

 ABBOTT INDIA   SHASUN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
SHASUN PHARMA
Mar-14
ABBOTT INDIA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs6,11094 6,486.2%   
Low Rs3,99646 8,763.2%   
Sales per share (Unadj.) Rs1,552.2214.2 724.7%  
Earnings per share (Unadj.) Rs188.85.3 3,538.4%  
Cash flow per share (Unadj.) Rs196.415.8 1,241.6%  
Dividends per share (Unadj.) Rs55.001.00 5,500.0%  
Dividend yield (eoy) %1.11.4 76.1%  
Book value per share (Unadj.) Rs796.653.3 1,493.4%  
Shares outstanding (eoy) m21.2556.62 37.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.30.3 997.5%   
Avg P/E ratio x26.813.1 204.3%  
P/CF ratio (eoy) x25.74.4 582.2%  
Price / Book Value ratio x6.31.3 484.1%  
Dividend payout %29.118.7 155.4%   
Avg Mkt Cap Rs m107,3763,958 2,713.1%   
No. of employees `0003.3NA-   
Total wages/salary Rs m3,9372,164 182.0%   
Avg. sales/employee Rs Th9,929.3NM-  
Avg. wages/employee Rs Th1,185.1NM-  
Avg. net profit/employee Rs Th1,207.7NM-  
INCOME DATA
Net Sales Rs m32,98512,127 272.0%  
Other income Rs m1,170229 510.1%   
Total revenues Rs m34,15512,356 276.4%   
Gross profit Rs m5,2451,009 519.8%  
Depreciation Rs m162594 27.3%   
Interest Rs m38415 9.2%   
Profit before tax Rs m6,215230 2,705.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203-73 -3,029.0%   
Profit after tax Rs m4,012302 1,328.0%  
Gross profit margin %15.98.3 191.1%  
Effective tax rate %35.4-31.7 -112.0%   
Net profit margin %12.22.5 488.2%  
BALANCE SHEET DATA
Current assets Rs m22,6556,884 329.1%   
Current liabilities Rs m6,6818,456 79.0%   
Net working cap to sales %48.4-13.0 -373.7%  
Current ratio x3.40.8 416.5%  
Inventory Days Days6562 105.1%  
Debtors Days Days29108 27.1%  
Net fixed assets Rs m8354,970 16.8%   
Share capital Rs m213113 187.6%   
"Free" reserves Rs m16,7152,875 581.4%   
Net worth Rs m16,9283,020 560.5%   
Long term debt Rs m01,817 0.0%   
Total assets Rs m24,16213,347 181.0%  
Interest coverage x163.71.6 10,537.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.40.9 150.3%   
Return on assets %16.85.4 312.0%  
Return on equity %23.710.0 236.9%  
Return on capital %36.913.3 277.3%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m3695,843 6.3%   
Fx outflow Rs m3,8072,173 175.2%   
Net fx Rs m-3,4383,669 -93.7%   
CASH FLOW
From Operations Rs m1,527398 384.1%  
From Investments Rs m-2,148-1,635 131.4%  
From Financial Activity Rs m-1,0241,309 -78.3%  
Net Cashflow Rs m-1,64671 -2,311.2%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.6 219.4%  
FIIs % 0.1 17.6 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 39.6 43.2%  
Shareholders   18,270 20,750 88.0%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Sep 19, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS